Business / Finance

RSS

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.

19 Dec 2013

Meda inks agreement to acquire ZpearPoint AS

Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion. Dental erosion is a common, growing condition that impacts all ages and for which there is currently no effective treatment. The condition is estimated to affect 15-50% of the population and it is sometimes referred to as the "new caries".

19 Dec 2013

Merck signs license agreement with CNIO for cancer drug development

Merck Serono, the biopharmaceutical division of Merck, today announced that a license agreement has been signed with the Spanish National Cancer Research Centre in Madrid in the area of cancer drug development. The global agreement will build upon CNIO research discoveries to encourage the development and commercialization of new compounds in the field of oncology.

18 Dec 2013

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Mylan Inc. today announced that it has received all regulatory approvals and has completed an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize a novel long-acting muscarinic antagonist compound for various indications.

18 Dec 2013

Paragonix Technologies successfully closes $1.1M convertible debt round

Paragonix Technologies, Inc., a medical device company based in Braintree, MA, developing the Sherpa product line for organ preservation and transportation, today announced that the Company's $1.1M convertible debt round has been successfully closed.

18 Dec 2013

Takeda expands commercial platform in Israel

Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.

18 Dec 2013

Mylan enters into agreement to resolve patent litigation related to Bexarotene Capsules

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. and Valeant Pharmaceuticals Luxembourg S.a.r.l that will resolve patent litigation related to Bexarotene Capsules, 75 mg.

17 Dec 2013

Epsilon inks multi-year renewal, expansion agreements with The Leukemia & Lymphoma Society

Epsilon, an Alliance Data company, has signed multi-year renewal and expansion agreements with The Leukemia & Lymphoma Society the world's largest voluntary health agency dedicated to finding cures for blood cancers. Epsilon has partnered with the LLS since the early 1990s, providing marketing services geared toward engaging LLS constituents across a range of fundraising and donor programs such as Light the Night, Team In Training and Man & Women of the Year.

17 Dec 2013

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has secured $38.5 million in initial closings under its Series B financing. In this round, investors Amgen Ventures, Celgene Corporation, and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers.

17 Dec 2013

Sealand Natural Resources signs exclusive distribution agreement with V-SELL Group

Sealand Natural Resources Inc., a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced an exclusive distribution agreement in Sweden with the V-SELL Group.

17 Dec 2013

SynCardia Systems raises $14M to fund the rapid growth of Total Artificial Heart

Privately held SynCardia Systems, Inc. announced today that it had raised $14 million to fund the rapid growth of the only approved medical device that eliminates the symptoms and source of end-stage heart failure, the SynCardia temporary Total Artificial Heart. The SynCardia Total Artificial Heart is the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.

17 Dec 2013

Norgine signs exclusive licensing agreement with Innovacell for ICEF15

Norgine B.V. and Innovacell today announced they have entered into an exclusive licensing agreement for Europe, SADAC and MENA for ICEF15. Innovacell and Norgine will co-develop ICEF15 and Norgine will commercialise the product. The start of the ICEF15 phase IIb clinical trial is imminent and it is anticipated that the first patient will be dosed in Q1 2014.

17 Dec 2013

Medical Daily announces marketing and distribution partnership with UBM Medica US

Medical Daily announced today a unique marketing and distribution partnership with UBM Medica US. Medical Daily is a source of breaking health news, scientific trends and innovations.

16 Dec 2013

MicroBiome Therapeutics announces completion of $1.3M bridge financing

MicroBiome TherapeuticsTM LLC, today announced completion of a $1.3 million bridge financing. It is intended to support completion of the company's two ongoing clinical studies and preparations for further clinical trials of lead product NM504, a microbiome modulator in development for type 2 diabetes and prediabetes. The bridge financing was led by current investor BVM Capital, who was joined in the round by other existing MBT investors.

16 Dec 2013

NYSE publicly traded industry selects EPGL's advanced technologies for development

EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.

16 Dec 2013

NHS Alliance collaborates with ITN Productions to launch NHS Alliance TV 2013

The NHS Alliance and ITN Productions have joined forces to release NHS Alliance TV 2013, an in-depth, sector-focussed news programme for healthcare professionals. Hosted by Natasha Kaplinsky from ITN's London studios, NHS Alliance TV was launched to over 500 industry leaders at the NHS Alliance Conference, and is now available on ITN's dedicated Healthcare News website.

16 Dec 2013

RT Oncology and Express Scripts enter into pharmaceutical drug distribution agreement

RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.

16 Dec 2013

Business / Finance

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Meda inks agreement to acquire ZpearPoint AS

Merck signs license agreement with CNIO for cancer drug development

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Paragonix Technologies successfully closes $1.1M convertible debt round

Takeda expands commercial platform in Israel

Mylan enters into agreement to resolve patent litigation related to Bexarotene Capsules

Epsilon inks multi-year renewal, expansion agreements with The Leukemia & Lymphoma Society

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Sealand Natural Resources signs exclusive distribution agreement with V-SELL Group

SynCardia Systems raises $14M to fund the rapid growth of Total Artificial Heart

Norgine signs exclusive licensing agreement with Innovacell for ICEF15

Medical Daily announces marketing and distribution partnership with UBM Medica US

MicroBiome Therapeutics announces completion of $1.3M bridge financing

NYSE publicly traded industry selects EPGL's advanced technologies for development

NHS Alliance collaborates with ITN Productions to launch NHS Alliance TV 2013

RT Oncology and Express Scripts enter into pharmaceutical drug distribution agreement

Savient gets bankruptcy court approval to sell all assets to Crealta

Centene updates 2013 financial guidance, announces financial guidance for 2014 fiscal year

Retrophin to acquire privately-held company, Kyalin Biosciences

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News